Synairgen (LON:SNG) Stock Price Down 0.2% – Should You Sell?

Synairgen plc (LON:SNG)’s share price dropped 0.2% during mid-day trading on Friday . The company traded as low as GBX 4.31 ($0.05) and last traded at GBX 4.39 ($0.06). Approximately 26,786 shares were traded during trading, a decline of 92% from the average daily volume of 316,815 shares. The stock had previously closed at GBX 4.40 ($0.06).

Synairgen Trading Down 0.2 %

The company has a market cap of £8.84 million, a PE ratio of -146.33 and a beta of -2.23. The stock’s 50 day moving average is GBX 4.48 and its 200-day moving average is GBX 4.51. The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09.

About Synairgen

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.